• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

March 19, 2014: Blood Products Advisory Committee Meeting Draft Agenda

FOOD AND DRUG ADMINISTRATION
Center for Biologics Evaluation and Research
109th Meeting of the Blood Products Advisory Committee
Great Room, Building 31
FDA White Oak Campus
10903 New Hampshire Avenue
Silver Spring, MD 20993
March 18-19, 2014

Wednesday, March 19, 2014: DRAFT AGENDA
Topic II: Review of the Research Programs in the Laboratory of Hemostasis, Division of Hematology, OBRR
9:00 a.m. Overview of CBER Research Programs Carolyn Wilson, Ph.D.
CBER, FDA
9:15 a.m. Overview of OBRR Research Programs CD Atreya, Ph.D.
OBRR, FDA
9:25 a.m. Overview of the Division of Hematology Research Program Basil Golding, M.D.
OBRR, FDA
9:40 a.m. Overview of the Laboratory of Hemostasis Basil Golding, M.D.
OBRR, FDA
10:25 a.m. Questions for the Speakers
10:40 a.m. Open Public Hearing
11:10 a.m. Closed Committee Discussion
11:45 a.m. Adjournment